Arboviral Diseases Branch, Centers for Disease Control and Prevention, 3150 Rampart Road, Fort Collins, CO 80521, United States.
Vaccine. 2010 Dec 10;29(1):58-64. doi: 10.1016/j.vaccine.2010.10.016. Epub 2010 Nov 4.
We reviewed adverse events following receipt of inactivated mouse brain-derived Japanese encephalitis (JE) vaccine reported to the U.S. Vaccine Adverse Event Reporting System (VAERS) from 1999 to 2009. During this period, VAERS received 300 adverse event reports following JE vaccination (24 per 100,000 doses distributed); 106 (35%) were classified as hypersensitivity reactions (8.4 per 100,000 doses) and four (1%) were classified as neurologic events (0.3 per 100,000 doses). Twenty-three (8%) reports described serious adverse events (1.8 per 100,000 doses distributed). There were no reports of encephalitis, meningitis, or Guillain-Barré syndrome. As reported previously, hypersensitivity reactions were common among persons receiving inactivated mouse brain-derived JE vaccine.
我们对 1999 年至 2009 年期间美国疫苗不良事件报告系统(VAERS)报告的接受灭活鼠脑源性日本脑炎(JE)疫苗后的不良事件进行了审查。在此期间,VAERS 收到了 300 例 JE 疫苗接种后的不良事件报告(每 10 万剂分布 24 例);106 例(35%)被归类为过敏反应(每 10 万剂 8.4 例),4 例(1%)被归类为神经系统事件(每 10 万剂 0.3 例)。23 份报告描述了严重不良事件(每 10 万剂分布 1.8 例)。没有脑炎、脑膜炎或格林-巴利综合征的报告。如前所述,过敏反应在接受灭活鼠脑源性 JE 疫苗的人群中很常见。